Code of Colorado Regulations
700 - Department of Regulatory Agencies
712 - Division of Professions and Occupations - Colorado Podiatry Board
3 CCR 712-1 - PODIATRY RULES AND REGULATIONS
Section 3 CCR 712-1.18 - RULES REGARDING THE USE OF BENZODIAZEPINE

Universal Citation: 3 CO Code Regs 712-1 ยง 18

Current through Register Vol. 47, No. 17, September 10, 2024

This Rule is promulgated pursuant to sections 12-20-204, 12-290-106(1)(a), and 12-30-109(6), C.R.S.

A. Licensees must limit any prescription for a continuous benzodiazepine to a 30-day supply, for any patient who has not been prescribed a benzodiazepine in the last 12 months.

Prior to prescribing the second fill of a benzodiazepine for a condition that is not exempt under section 12-280-404(4) (a.5) C.R.S., a licensee must comply with the requirements of section 12-280-404(4), C.R.S.

B. The limitation stated in Section (A) of this Rule does not apply to patients for whom licensees prescribe benzodiazepines for the following conditions:

1. Epilepsy;

2. A seizure, a seizure disorder, or a suspected seizure disorder;

3. Spasticity;

4. Alcohol withdrawal; or

5. A neurological condition, including a post-traumatic brain injury or catatonia.

C. These rules do not require or encourage abrupt discontinuation, limitation, or withdrawal of benzodiazepines. Licensees are expected to follow generally accepted standards of podiatry practice, based on an individual patient's needs, in tapering benzodiazepine prescriptions.

Disclaimer: These regulations may not be the most recent version. Colorado may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.